Skip to content
Recall Observatory FDA recall evidence

Drug product

Phenylephrine HCI Injection, USP, 10mg/mL, packaged in a) 5 mL Vial, 50 mg/5 mL (NDC 66758-016-03), 25 x 5 mL Vials per carton (NDC 66758-016-04) and b) 10 mL Vials, 100 mg/10 mL (NDC 66758-017-01), Rx only, Manufactured for: Sandoz Inc., Princeton, NJ 08540.

D-1514-2016

August 24, 2016

Class II

Product summary

Firm
Sandoz Inc
Event
Event 75032
Status
Terminated
Classification
Class II
Quantity
a) 1,584 cartons; b) 62,170 vials
Official record key
drug-enforcement:D-1514-2016

Official wording

Reason: Lack of Assurance of Sterility: a recent FDA inspection at the manufacturing firm raised concerns that product sterility may be compromised.

Code information: Lot #: a) 091914, Exp 09/16; b) 080114, Exp 08/16; 090414, 092614, Exp 09/16

Distribution pattern: Nationwide and Puerto Rico

Derived failure modes

  • Sterility assurance

    reason.sterility_assurance · v1.0.0

    Lack of Assurance of Sterility